TerminatedNo phase
Utilization of MAsS in Patients Undergoing LT for HCC
Reason given: Discontinued by Amra Medical due to funding.
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Columbia University Irving Medical CenterNew York, United StatesNo longer taking part
Trial details
- Who runs it
- Columbia University
- Trial code
- NCT05184283
- Record updated
- 7 December 2023
- Original description
The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.Read full original descriptionShow less
Longitudinal Assessment of Muscle Health in Patients Undergoing Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.
Inclusion: Age between 18 and 75 years; Diagnosis of cirrhosis and HCC; Listed or in evaluation for liver transplantation.
Exclusion: History of prior solid organ transplantation; In evaluation or listed for any other solid organ transplant (other than liver transplant); Contraindication to MR examination; Metastatic HCC.